TargetRx Atlas

mRNA_ID Gene Name drug_ID drug_Name Disease RNA_exp_pattern Evidence Details
ENST00000508487 CXCL2 NA NA non-small cell lung cancer up-regulated predicted more...
ENST00000508487 CXCL2 NA NA ovarian cancer up-regulated predicted more...
ENST00000508487 CXCL2 NA Neurotropin non-alcoholic fatty liver disease down-regulated validated more...
ENST00000508487 CXCL2 NA 3-Aminobenzamide rheumatoid arthritis down-regulated validated more...
ENST00000508487 CXCL2 NA Xia-yu-xue decoction liver fibrosis down-regulated validated more...
ENST00000508487 CXCL2 NA TCLPA5 neuroinflammation down-regulated validated more...
ENST00000508487 CXCL2 DB00877 Sirolimus acute kidney injury down-regulated validated more...
ENST00000508487 CXCL2 NA Trinitrobenzene sulfonic acid inflammatory bowel disease down-regulated validated more...
ENST00000508487 CXCL2 DB01166 Cilostazol bipolar disorder down-regulated validated more...
ENST00000508487 CXCL2 DB09074 Olaparib chronic obstructive pulmonary disease down-regulated validated more...
ENST00000508487 CXCL2 DB06655 Liraglutide acute myocardial infarction down-regulated validated more...
ENST00000508487 CXCL2 DB09302 Alirocumab alcoholic liver disease down-regulated validated more...